Drug intelligence / Profile preview

KOS-1584

Development stage
Phase 2
Lead developer
Bristol Myers Squibb
Modality
RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
Administration
Intravenous
01

Overview

KOS-1584 is a second-generation synthetic epothilone with potential antineoplastic (anticancer) activity. It acts as a microtubule-stabilizing agent by binding to tubulin and inducing microtubule polymerization, which leads to rapid G2/M cell cycle arrest and apoptosis in cancer cells. Compared to earlier epothilones such as Epothilone D, KOS-1584 demonstrates higher potency (3–12 fold), improved pharmacokinetic properties including enhanced tumor tissue penetration and reduced central nervous system exposure, and favorable tolerability. It was developed primarily for the treatment of advanced solid tumors—including non-small cell lung cancer—and has shown activity in various tumor types resistant to taxanes[2][3][4][5][6][7][8].

Other names
epothilone KOS-1584
02

Targets

TUBB (Tubulin (alpha and beta subunits))

Beyond the preview

Go deeper on KOS-1584.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on KOS-1584.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call